Documente Academic
Documente Profesional
Documente Cultură
College of Nursing
Valenzuela Campus
A Case Study
Presented to:
Ms. Vanessa O. Umali, R.N. MAN
Presented by:
Maria Paula M. Bungay
July 26, 2015
TABLE OF CONTENTS
I. Introduction
II. Objectives
III. Patients Profile
IV. Anatomy and Physiology
V. Pathophysiology
VI. Laboratory Examination Results
VII. Gordons Assessment
VIII. Nursing Care Plans
IX. Drug Study
X. Health Teachings
I. Introduction
In the present generation, we cannot deny the reality that different diseases sprout as
life progresses. The world is in the generation where diseases are widespread and the medical
fields are doing their further research in order to stop them. Being responsible for ones health is
very important for it builds the foundation of a healthy body. It is our choice to live a disease free
body. It is always our choice of what food will you eat, how much sleep you need, etc. There are
a lot of fashion trends in the world that will make each individuals life a masterpiece, but the
best fashion trend at present is a fit, healthy body.
Intestinal obstruction is significant mechanical impairment or complete arrest of the
passage of contents through the intestine. Symptoms include cramping pain, vomiting,
constipation, and lack of flatus. Diagnosis is clinical, confirmed by abdominal x-rays. Treatment
is fluid resuscitation, nasogastric suction, and, in most cases of complete obstruction, surgery.
According to Bordeianou and Yeh of Wolters Kluwers, Bowel obstruction occurs when
the normal flow of intraluminal contents is interrupted. Obstruction can be functional (due to
abnormal intestinal physiology) or due to a mechanical obstruction, which can be acute or
chronic. Advanced small bowel obstruction leads to bowel dilation and retention of fluid within
the lumen proximal to the obstruction, while distal to the obstruction, as luminal contents pass,
the bowel decompresses. If bowel dilation is excessive, or strangulation occurs, perfusion to the
intestine can be compromised leading to necrosis or perforation, complications, which increase
the mortality, associated with small bowel obstruction.
The most common causes of mechanical small bowel obstruction are postoperative
adhesions and hernias. Other etiologies of small bowel obstruction include disease intrinsic to
the wall of the small intestine (eg, tumors, stricture, intramural hematoma) and processes that
cause intraluminal obstruction (eg, intussusception, gallstones, foreign bodies).
Acute, mechanical small bowel obstruction is a common surgical emergency. It is
estimated that over 300,000 laparotomies per year are performed in the United States for
adhesion-related obstructions. Ischemia, which complicates 7 to 42 percent of bowel
obstructions, significantly increases mortality associated with bowel obstruction.
The small bowel is involved in about 80 percent of cases of mechanical intestinal
obstruction. The incidence is similar for males and females. In one Polish study of adult
patients, the average age of patients with acute obstruction was 64 years, women comprised 60
percent of the group, and the small bowel was affected in 76 percent.
In addition, I have learned and gained new knowledge regarding on Intestinal
obstruction. The in-depth understanding of the etiology, pathophysiology, clinical manifestations,
diagnosis, treatment and prevention of this condition has yield and enhanced my acquired
knowledge. As a student nurse, I also believed that actual interaction with the patient who has
the condition being studied can make it easier to understand. Also, to be able to learn
completely, one must be able to know how the concepts learned be applied into the actual
clinical practice.
The knowledge I acquired through this study will give me the opportunity to improve my
capability to deliver efficient and appropriate interventions and information to a variety of
population. The knowledge, skills and attitude that comprise an effective nurse will be of high
regard to promote a reduction in the morbidity and mortality rate. (http://www.uptodate.com/).
II. Objectives
Nurse-Centered
After the completion of this case study, the nurse will be able to:
1.
Understand the current statistics and latest trend regarding Intestinal Obstruction
partial probably sec to Colonic Malignancy.
2.
Describe factually, the personal and pertinent family history of the patient and relate it to the
present condition.
3.
4.
5.
Determine the predisposing and precipitating factors and the signs and symptoms and
relate to the disease process.
6.
Enumerate and describe the diagnostic and laboratory procedures as well as the nursing
responsibilities in relation to the disease condition
7.
Enumerate the different treatment modalities and their indication specifically for the patients
condition.
8.
Identify the pharmacologic treatment provided to the patient, relate the actions of each drug
with the disease process and evaluate the patients response to the medications given.
9.
Identify nursing diagnoses, formulate short-term goals, carry out appropriate interventions
and evaluate the plan.
10. Appraise the effectiveness of medical and surgical nursing management in treating the
patient.
11. List the preventive measure for the occurrence of Intestinal Obstruction partial probably sec
to Colonic Malignancy for the benefit of the general public.
Patient Centered
After the completion of this case study, the patient will be able to:
1. Report understanding of the disease process.
2. Understand the indications of the different diagnostic procedures and medical
management involved in her care.
3. Cooperate with the necessary medical and nursing interventions.
4. Adhere with the health teachings provided.
5. Understand the different ways of health promotion and prevention in relation to the
disease condition.
associated nausea, vomiting, change in bowel habits, hematochezia, melena, jaundice and
fever. Patient consulted at PGH, Abdominal X-ray revealed dilated small bowels. He was then
referred to the institution for further management.
PHYSICAL ASSESSMENT
Physicians Physical Assessment done by the Resident on Duty (July 2, 2015, lifted from the
patient's chart)
Height: 56
Weight: 81 kg
Vital Signs as follows:
T: 36.9 C
RR: 18cpm
SAO2: 97%
GENERAL SURVEY
Mr. Isaw, Assessed/received patient lying on bed, awake, conscious, responsive, and
coherent. With the following vital signs:
Temperature: 36.7 C
Heart rate: 70 bpm
Respiratory rate: 20 bpm
Blood Pressure: 140/90 mmHg
SAO2: 96%
NUTRITIONAL STATUS
Upon admission, Mr. Isaw was placed on NPO and IVF of D5LR 1 x Q8. CBC, BT,
PTPTT, FBS, BUN, CREA, Na, K, Cl, 12-LECG, Chest X-ray PA, abdominal series, and
Urinalysis were requested. NGT and Foley Catheter were inserted.
SKIN
10
11
> Patient was able to answer well when asked of her complete name, birth date and age.
URINARY SYSTEM
> Patient has indwelling Foley Catheter
REPRODUCTIVE SYSTEM
> The patient refused to be assessed with her external reproductive organ but she
verbalized that she has minimal vaginal bleeding and complain of pain when secretions are
expelled.
REVIEW OF SYSTEM
Integumentary System
The patient has no history of bruises in both upper and lower extremities.
Head
The patient had no history of any form of head injuries.
Eyes
Patient had no history of any eye problems.
Ears and Hearing
Patient had no history of smelly discharges on both ears, and no complaints of hearing
impairment.
Breast and Axillae
The patient had no history of breast nodules, no enlargement, no tenderness, no pain and
unusual discharges.
Respiratory System
12
13
CRANIAL NERVE
ASSESSMENT
TECHNIQUE
EXPECTED
OUTCOME
ACTUAL FINDINGS
I: Olfactory
Type: Sensory
Function: Smell
Client is able to
identify different
smell with each
nostril separately
and with eyes
closed unless such
condition like colds
is present.
II: Optic
Type: Sensory
Function: Vision
Provide adequate
lighting and ask client
to read words on a
newspaper held at a
distance of 36 cm (14
inches) with each eye
first then both eyes.
V: Trigeminal
Type: Sensory
Function: Sensation
of cornea
VII: Facial
Type: Motor
Function: Facial
movements
14
VIII:
Vestibulocochlear/
acoustics
Type: Sensory
Function: Hearing
IX. Glossopharyngeal
& X: Vagus
Type: Motor
Function:
Swallowing and
Speaking
-There is symmetric,
strong contraction of
the trapezious
muscles.
-There is strong
contraction of the
sternocleidomastoid
muscle on the side
opposite to the turned
face.
XII: Hypoglossal
Type: Motor
Function: Movement
and strength of
tongue
15
Inside this tube, ingested food and fluid, along with secretions from various glands, are
efficiently processed. First, they are broken down into their separate constituents; then the
desired nutrients, water, and electrolytes are absorbed into the blood for use by the cells, and
waste elements are eliminated from the body. Within this system, the liver can reassemble the
component nutrients into new materials as they are needed by the body. For example, the
proteins in milk are digested by enzymes in the digestive tract, producing the component amino
acids, which are then absorbed into the blood. The individual amino acids are used by the liver
cells to produce new proteins, such as albumin or prothrombin, or they may circulate as they are
in the amino acid pool in the blood to be taken up by individual cells as necessary.
The peritoneal cavity refers to the potential space between the parietal and visceral
peritoneum. A small amount of serous fluid is present in the cavity to facilitate the necessary
movement of structures such as the stomach. Numerous lymphatic channels drain excessive
fluid from the cavity.
Because serous membranes are normally thin, somewhat permeable, and highly
vascular, the peritoneal membranes are useful as an exchange site for blood during peritoneal
dialysis in patients with kidney failure. However, such an extensive membrane may also facilitate
the spread of infection or malignant tumor cells throughout the abdominal cavity or into the
general circulation.
The mesentery is a double layer of peritoneum that supports the intestines and
conveys blood vessels and nerves to supply the wall of the intestine. The mesentery attaches
the jejunum and ileum to the posterior (dorsal) abdominal wall. This arrangement provides a
balance between the need for support of the intestines and the need for considerable flexibility
to accommodate peristalsis and varying amounts of content.
The greater omentum is a layer of fatty peritoneum that hangs from the stomach like an
apron over the anterior surface of the transverse colon and the small intestine. The lesser
omen-tum is part of the peritoneum that suspends the stomach and duodenum from the liver.
When inflammation develops in the intestinal wall, the greater omentum, with its many lymph
nodes, tends to adhere to the site, walling off the inflammation and temporarily localizing the
source of the problem. Inflammation of the omentum and peritoneum may lead to scar tissue
and the formation of adhesions between structures in the abdominal cavity, such as loops of
intestine, restricting motility and perhaps leading to obstruction.
Intestinal Obstruction
Intestinal obstruction refers to a lack of movement of the intestinal contents through
the intestine. Because of its smaller lumen, obstructions are more common and occur more
rapidly in the small intestine, but they can occur in the large intestine as well. Depending on the
cause and location, obstruction may manifest as an acute problem or a gradually developing
situation. For example, twisting of the intestine could cause sudden total obstruction, whereas
Intestinal obstruction occurs in two forms. Mechanical obstructions are those resulting
from tumor, adhesions, hernias, or other tangible obstructions. Functional, or adynamic,
obstructions result from neurologic impairment, such as spinal cord injury or lack of propulsion
in the intestine, and are often referred to as paralytic ileus. While the end result can be the
same, these types manifest somewhat differently and require different treatment.
Colon
The colon is the last part of the digestive system in most vertebrates; it extracts water
and salt from solid wastes before they are eliminated from the body, and is the site in which
flora-aided (largely bacteria) fermentation of unabsorbed material occurs. Unlike the small
intestine, the colon does not play a major role in absorption of foods and nutrients. However,
the colon does absorb water, potassium and some fat soluble vitamins.
In mammals, the colon consists of four sections: the ascending colon, the transverse
colon, the descending colon, and the sigmoid colon (the proximal colon usually refers to the
ascending colon and transverse colon). The colon, cecum, and rectum make up the large
intestine.
The location of the parts of the colon are either in the abdominal cavity or behind it
in
important if either vessel is occluded. However, recent studies conducted with improved
imaging technology have questioned the actual existence of this vessel, with some experts
calling for the abolition of the terms from future medical literature.
Venous drainage usually mirrors colonic arterial supply, with the inferior mesenteric vein
draining into the splenic vein, and the superior mesenteric vein joining the splenic vein to form
the hepatic portal vein that then enters the liver.
Lymphatic drainage from the entire colon and proximal two-thirds of the rectum is to the
paraaortic lymph nodes that then drain into the cisterna chyli. The lymph from the remaining
rectum and anus can either follow the same route, or drain to the internal iliac and superficial
inguinal nodes. The pectinate line only roughly marks this transition.
Ascending colon
The ascending colon, on the right side of the abdomen, is about 25 cm long in humans.
It is the part of the colon from the cecum to the hepatic flexure (the turn of the colon by the
liver). It is secondarily retroperitoneal in most humans. In ruminant grazing animals, the cecum
empties into the spiral colon.
Anteriorly it is related to the coils of small intestine, the right edge of the greater
omentum, and the anterior abdominal wall. Posteriorly, it is related to the iliacus, the iliolumbar
ligament, the quadratus lumborum, the transverse abdominis, the diaphragm at the tip of the
last rib; the lateral cutaneous, ilioinguinal, and iliohypogastric nerves; the iliac branches of the
iliolumbar vessels, the fourth lumbar artery, and the right kidney. The ascending colon is
supplied by parasympathetic fibers of the vagus nerve (CN X).
Arterial supply of the ascending colon comes from the ileocolic artery and right colic artery,
both branches of the SMA. While the ileocolic artery is almost always present, the right colic
may be absent in 515% of individuals.
Transverse colon
The transverse colon is the part of the colon from the hepatic flexure to the splenic
flexure (the turn of the colon by the spleen). The transverse colon hangs off the stomach,
attached to it by a wide band of tissue called the greater omentum. On the posterior side, the
transverse colon is connected to the posterior abdominal wall by a mesentery known as the
transverse mesocolon.
The transverse colon is encased in peritoneum, and is therefore mobile (unlike the parts
of the colon immediately before and after it). Cancers form more frequently further along the
large intestine as the contents become more solid (water is removed) in order to form feces.
The proximal two-thirds of the transverse colon is perfused by the middle colic artery, a
branch of SMA, while the latter third is supplied by branches of the IMA. The "watershed" area
between these two blood supplies, which represents the embryologic division between the
midgut and hindgut, is an area sensitive to ischemia.
Descending colon
The descending colon is the part of the colon from the splenic flexure to the beginning of
the sigmoid colon. The function of the descending colon in the digestive system is to store food
that will be emptied into the rectum. It is retroperitoneal in two-thirds of humans. In the other
third, it has a (usually short) mesentery. The arterial supply comes via the left colic artery.
Sigmoid colon
The sigmoid colon is the part of the large intestine after the descending colon and before
the rectum. The name sigmoid means S-shaped (see sigmoid). The walls of the sigmoid colon
are muscular, and contract to increase the pressure inside the colon, causing the stool to move
into the rectum.
The sigmoid colon is supplied with blood from several branches (usually between 2 and 6) of
the sigmoid arteries, a branch of the IMA. The IMA terminates as the superior rectal artery.
Sigmoidoscopy is a common diagnostic technique used to examine the sigmoid colon.
Redundant colon
One variation on the normal anatomy of the colon occurs when extra loops form,
resulting in a longer than normal organ. This condition, referred to as redundant colon, typically
has no direct major health consequences, though rarely volvulus occurs resulting in obstruction
and requiring immediate medical attention.[4] A significant indirect health consequence is that
use of a standard adult colonoscope is difficult and in some cases impossible when a
redundant colon is present, though specialized variants on the instrument (including the
pediatric variant) are useful in overcoming this problem.
Standing gradient osmosis
Water absorption at the colon typically proceeds against a transmucosal osmotic
pressure gradient. The standing gradient osmosis is a term used to describe the reabsorption
of water against the osmotic gradient in the intestines. This hypertonic fluid creates an osmotic
pressure that drives water into the lateral intercellular spaces by osmosis via tight junctions and
adjacent cells, which then in turn moves across the basement membrane and into the
capillaries.
Functions of the Colon
There are differences in the large intestine between different organisms, the large
intestine is mainly responsible for storing waste, reclaiming water, maintaining the water
balance, absorbing some vitamins, such as vitamin K, and providing a location for flora-aided
fermentation.Vitamin K is essential as a coagulation factor.
By the time the chyme has reached this tube, most nutrients and 90% of the water have
been absorbed by the body. At this point some electrolytes like sodium, magnesium, and
chloride are left as well as indigestible parts of ingested food (e.g., a large part of ingested
amylose, protein which has been shielded from digestion heretofore, and dietary fiber, which is
largely indigestible carbohydrate in either soluble or insoluble form). As the chyme moves
through the large intestine, most of the remaining water is removed, while the chyme is mixed
with mucus and bacteria (known as gut flora), and becomes feces. The ascending colon
receives fecal material as a liquid. The muscles of the colon then move the watery waste
material forward and slowly absorb all the excess water. The stools get to become semi solid
as they move along into the descending colon. The bacteria break down some of the fiber for
their own nourishment and create acetate, propionate, and butyrate as waste products, which
in turn are used by the cell lining of the colon for nourishment. No protein is made available. In
humans, perhaps 10% of the undigested carbohydrate thus becomes available; in other
animals, including other apes and primates, who have proportionally larger colons, more is
made available, thus permitting a higher portion of plant material in the diet. This is an example
of a symbiotic relationship and provides about one hundred calories a day to the body. The
large intestine produces no digestive enzymes - chemical digestion is completed in the small
intestine before the chyme reaches the large intestine. The pH in the colon varies between 5.5
and 7 (slightly acidic to neutral).
Age 50 or older.
Diarrhea, constipation, or feeling that the bowel does not empty completely.
Vomiting.
A specimen removed from a patient with colonic carcinoma
V. Pathophysiology
Pathophysiology of Intestinal obstruction
2 types of obstructions
Mechanical:
(+) Physical
obstruction or
increased pressure
from walls creating a
blockage
Functional:
Intestinal muscles
cannot propel the
contents along the
bowel
Increased pressure on
intestinal wall causes
more fluid to enter
intestine
Decreased blood
pressure &pressure on
Continued
hypovolemic
shock
intestinal
wall causes
edema, ischemia and
decreased peristalsis
Predisposing factors:
Colorectal polyps
Family history
Previous colorectal
cancer
Ulcerative colitis
/colonic crohns
disease
Diagnostic test:
SigmoIdoscopy
Digital Rectum
Exam
Surgical Treatment:
Colonoscopy
Virtual Colonoscopy
Precipitating factors:
Patient broke her right leg
due to falling on the stairs
Precipitating factors:
Smoking
Alcohol drinking
(+)Lack of exercise
Etiology:
Unknown
Abnormal
proliferation of cells
in the colon area
Rectal bleeding
Bloody stools
(+) Fatigue
Constipation
(+)Diarrhea
Arising from
epithelial lining of the
intestine
Continuous plorifetation of
cells in the polyps
Polypectomy
Reduction likelihood
of regrowth
Exposure to carcinogens
Uncontrolled
Increase in
proliferation
COLON
CANCER
size
of cells in
the tumor
Complications
DEATH occur
Diagnostic test:
SigmoIdos
copy
VI.
Laboratory Examination
Results
Diagnostic/
Laboratory
Procedures
1. Complete Blood
Count
Indications or
Purposes
Results
Analysis and
Interpretation of
results
Hgb: 153
N: 115-175 g/L
Hct: 0.44
N: 0.40-0.52
CBC is a
screening test,
used to diagnose
and manage
numerous
diseases. The
results can reflect
problems with
fluid or loss of
blood.
a. Hemoglobin
Date ordered/
Date of Results:
July 2, 2015
b. Hematocrit
Date ordered/
Date of Results:
July 2, 2015
Hemoglobin
determines the
RBC that carries
oxygen and
carbon dioxide
throughout the
body
Hematocrit
determines the
concentration of
RBC within the
blood volume
c. RBC
Date ordered/
Date of Results:
July 2, 2015
volume.
RBC: 4.93
N:4.5-6.2
WBC: 13.0
N: 5-10x 109/L
An RBC count is
a blood test that
measures
how
many red blood
cells (RBCs) you
have.
RBCs
contain
hemoglobin,
which
carries
oxygen.
How
much
oxygen
your body tissues
get depends on
how many RBCs
you have and
how well they
work.
d. WBC
Date ordered/
Date of Results:
July 2, 2015
fight infections by
attacking
bacteria, viruses,
and germs that
invade the body.
White blood cells
originate in the
bone marrow, but
circulate
throughout
the
bloodstream.
DIFFERENTIAL
COUNT
a. Segmenters
Segmenters: 0.84
Date ordered/
Date of Results:
July 2, 2015
A type of white
blood cell that
respond
to
bacterial
infections. Where
the blood count
has high levels of
segmenters, this
indicates
the
presence of a
bacterial infection.
Where there is a
low
level
of
segmenters, the
patient is likely to
be suffering from
a viral infection or
N: 0.55-0.65
an autoimmune
disease.
b.Lymphocytes
Lymphocytes: 0.27
Date ordered/
Date of Results:
July 2, 2015
Lymphocytes are
responsible
for
immune
responses. There
are two main
types
of
lymphocytes:
B
cells and T cells.
The B cells make
antibodies
that
attack
bacteria
and toxins while
the T cells attack
body
cells
themselves when
they have been
taken over by
viruses or have
become
cancerous.
Lymphocytes
secrete products
(lymphokines)
that modulate the
functional
activities of many
other types of
cells and
are
often present at
sites of chronic
inflammation.
N: 0.25-0.35
Normal
count
of
lymphocytes indicates
that
there
is
no
presence of infection in
the body
c. Eosinophils
N: 0.02-0.04
0.00
Date ordered/
Date of Results:
July 2, 2015
Eosinophils are a
specific type of
white blood cell
that protects your
body against
certain kinds of
germs, mainly
bacteria and
parasites. They're
also what causes
you to have
allergic reactions.
d. Monocytes
Date ordered/
Date of Results:
July 2, 2015
0.06
Monocytes are a
type
of
white
blood cell that
fights off bacteria,
viruses and fungi.
Monocytes
are
the biggest type
of white blood cell
in the immune
system. Originally
formed in the
bone
marrow,
they are released
into our blood and
tissues.
When
certain
germs
enter the body,
they quickly rush
N: 0.03-0.06
to the
attack.
site
for
e. Basophils
Date ordered/
Date of Results:
July 2, 2015
N: 0.00-0.01
Platelet Count:
311
Platelet Count:
150- 400 x 109/L
Basophils
are
granulocytic white
blood cells that
are active in the
inflammatory
response.
They
are mostly found
in the skin and
mucosa tissues,
which are the
tissues lining the
openings into the
body.
They
represent about
1% of all white
blood cells in the
body.
Platelet Count
Date ordered/
Date of Results:
July 2, 2015
0.00
A platelet count is
a test to measure
how
many
platelets you have
in your blood.
Platelets are parts
of the blood that
help the blood
clot. They are
smaller than red
or white
cells.
blood
Nursing Responsibilities:
BEFORE
1. Explain to the patient the procedure and its purposes.
2. If the patient has eaten a meal with high sodium content in the past 24 hours, this should
be noted.
3. Be sure not to draw blood, which has infused IVF.
4. Note if patients on a diet that restricts sodium and other nutrients.
5. Note other conditions such as diabetes.
6. Carefully watch for signs of electrolyte imbalance.
7. Perform a complete cephalocaudal assessment especially cardiac assessment and vital
signs.
8. Make sure to have the right patient, specimen and method.
DURING
1. Clean injection site with alcohol.
2. Lower the patients arm to dilate the veins.
3. Apply tourniquet and ask the patient to open and close fist.
4. Remove the tourniquet when drawing the final tube of blood.
AFTER
1. Note for any signs of discomfort or bruising at the puncture site.
2. Provide pressure at the puncture site to stop bleeding and reduce bruising.
3. Apply warm compress to puncture site to relieve discomfort.
4. Send the specimen at the laboratory.
B. Blood Chemistry
Diagnostic/ Laboratory
Procedures
Date ordered
Date results in
Indications or
Purposes
Date ordered:
A serum creatinine
test which
measures the level
of creatinine in your
blood can
indicate whether
your kidneys are
working properly.
70.10 umol/L
It regulates body
water along with
potassium. It is
responsible
for
nerve
conduction
and contraction of
muscle.
Na: 141
Results
Normal Value
(Units used in
the hospital)
Analysis and
Interpretation of
results
2. CLINICAL
CHEMISTRY TEST
Creatinine
July 2, 2015
Date of Results:
July 2, 2015
Sodium
Date ordered:
July 2, 2015
Date of Results:
July 2, 2015
N: 71-115
umol/L
N: 135-148
mmol/L
Potassium
Date ordered:
July 2, 2015
Date of Results:
July 2, 2015
Chloride
Date ordered:
July 2, 2015
Date of Results:
July 2, 2015
It is a mineral,
which with Sodium
and
Calcium
maintains
normal
heart rhythm and
regulates
water
balance.
A chloride test
measures the level
of chloride in your
blood or urine.
Chloride is one of
the most important
electrolytes in the
blood. It helps keep
the amount of fluid
inside and outside
of your cells in
balance. It also
helps maintain
proper blood
volume, blood
pressure, and pH of
your body fluids.
Tests for sodium,
potassium, and
bicarbonate are
usually done at the
same time as a
blood test for
chloride.
K: 4.10
104.4
N: 3.5-5.3
mmol/L
N: 98-107
mmol/L
Alanine Aminotrans
liquid
Date ordered:
July 2, 2015
Date of Results:
July 2, 2015
Aspartate Aminotrans
liquid
Date ordered:
July 2, 2015
Date of Results:
July 2, 2015
19.0 U/L
18.6 U/L
N:10.0-44.0
N: 10.0-34.0
Calcium Gen 2
Date ordered:
July 2, 2015
Date of Results:
July 2, 2015
2.18 mmol/L
N: 2.20-2.75
NURSING RESPONSIBILITIES
BEFORE
1. Confirm the patients identity using two patient identifiers according to facility policy.
2. Explain the procedure and the indication.
3. Inform the patient that the test requires blood sample, and explain that he may
experience slight discomfort from the tourniquet and the needle puncture.
4. Instruct the patient that he doesnt need to restrict food and fluids. For triglycerides she
should not eat 12 hours before procedure.
5. Notify the laboratory and practitioner about any medications the patient is taking that
may affect test results; they may need to be restricted.
DURING
1. Perform venipuncture and collect the sample in a 3- or 4-mL clot activator tube.
2. Handle sample gently to prevent hemolysis.
AFTER
1. A report of the results will be sent to the requesting Health Care Provider, who will
discuss the results with the patient.
2. Depending on the results of this procedure, additional testing may be performed to
evaluate or monitor progression of the disease process and determine the need for a
change in therapy.
3. Evaluate test results in relation to the patient's symptoms and other tests performed.
Diagnostic/
Laboratory
Procedures
Date ordered
Date results
in
2. Urinalysis
Date ordered:
July 2, 2015
Date of
Results:
July 2, 2015
Indications or
Purposes
Urinalysis yields
a large amount
of information
about possible
disorders of the
kidney and lower
urinary tract, and
systemic
disorders that
alter urine
composition
Results
Color:
Normal Value
(Units used in
the hospital)
Analysis
Interpretation
Yellow
Amber
The result is
Yellow
Transparenc
y:
Slightly
turbid
clear 4.8-7.8
SP Gravity:
1.015-1.025
1.020
Sugar:
Negative
There is no pr
suga
Negative
There is no pr
protei
negative
Protein: +2
RBC: 2.5
Pus cells: 13
Epithelial
0.1/HPF
Indicates no pr
infectio
0.2/HPG
Few
cells:
few
Mucus
threads:
few
Indicate p
Infectio
Few
The kidney is in
function.
BEFORE
1. Check the doctors order.
2. Check the right client.
3.
B.
C.
D.
Nutrition/Metabolism
o
Elimination
o
Activity/Exercise
o
E.
F.
G.
Sexuality/Reproductive
o
Married
A father of 3 children
No history of STDs
Cognitive/Perceptual
o
College graduate
Roles/Relationship
o
Married
With 3 children
H.
I.
J.
Self Perception/Self-Concept
o
Value/Belief
o
A Roman Catholic
Coping/Stress
o
Copes up with problems by talking about it with the family and finds ways
to resolve it together
K.
L.
Sleep/Rest
o
No difficulties in sleeping
Medication History
o
S:
NURSING
SCIENTIFIC
DIAGNOSIS
EXPLANATION
Decrease
cardiac output
O : The patient
related to altered
Decreased blood
manifested the
heart rate/rhythm
supply
following:
Afebrile
Conscious and
coherent
Pale palpebral
Decreased venous
return
Decreased
conjunctiva
amount of blood
expelled by ventricles
time of 3
seconds
manifest:
Decreased skin
turgor
Sunken eyeballs
Sudden weight
loss
Short term:
NURSING
INTERVENTIONS
1.
Establish
RATIONALE
1.
EXPECTED
OUTCOME
To gain
Short term:
therapeutic
trust of the
The patient
nursing
relationship
patient
shall have
interventions, the
To note any
participated in
patient will
patients
abnormaliti
activities that
participate in
general
es
reduce the
condition
To have
workload of the
Take and
baseline
heart.
record the
data
2.
3.
heart.
Assess
patients vital
.
4.
Decreasedcardiac
output
OBJECTIVES
5.
2.
3.
4.
For comfort
signs
and
Provide
hygiene to
morning care
the patient
Evaluate
5.
To assess
client reports
for signs of
and evidence
poor
of extreme
ventricular
fatigue,
function
intolerance of
and/or
activity and
impending
progressive
cardiac
shortness of
failure
Decreased urine
output
breath
6.
Monitor
6.
To note
cardiac
effectivene
Vital signs
rhythm
ss of
taken:
continuously
medication
Decrease
T:36.9
7.
RR: 21
stimuli;
HR: 116
provide quiet
7.
adequate
environment
BP: 150/170
8.
9.
Schedule
To promote
rest
8.
To
activities and
maximize
assessments
rest periods
Instruct client
9.
Which can
to avoid/limit
cause
activities
changes in
10. ncourage
relaxation
techniques
11. Provide for
cardiac
pressures
10. To reduce
anxiety and
diet
conserve
restrictions
energy
12. Encourage
11. To maintain
changing
adequate
positions
nutrition
slowly,
12. To reduce
dangling legs
risk for
before
orthostatic
standing
hypotensio
13. Give
information
n
13. To provide
about
encourage
positive signs
ment
of
improvement
NURSING
SCIENTIFIC
DIAGNOSIS
EXPLANATION
OBJECTIVES
NURSING INTERVENTIONS
RATIONALE
EXPECTED
OUTCOME
S:
Ineffective
Ineffective tissue
Short term:
1.
Establish
1.
To build a
Short term:
therapeutic
good and
O : The patient
Perfusion related
in oxygen resulting in
of nursing
relationship
trusting
shall have
manifested the
to decreased
interventions,
Assess patients
relationship
verbalized
following:
cardiac output
general condition
with the
understanding
abrupt increase in
verbalize
patient
of condition,
understanding
To assess for
therapy
Vital signs
of condition,
that contributes to
complications
regimen, side
taken:
vasoconstriction of small
therapy
the patients
To note and
effects of
T:36.9
regimen, side
complaint.
assess for
medications,
RR: 21
effects of
Note current
complicatons
and when to
HR: 116
tone. Prolonged
medications,
situation or
Affecting
contact
BP: 150/170
elevations of pressure
and when to
presence of
systemic
healthcare
contact
circulation or
provider.
healthcare
affect perfusion to
perfussion
manifest:
the microcirculation, 2 of
provider.
Hypertension
2.
3.
3.
4.
Client at
olyguria
which, remodeling of
capillary refill
conditions
venous
associated with
stasis, vessel
of arterioles and
thrombus or emboli
wall injury
Note location of
and
restrictive clothing,
hypercoagula
pressure dressings,
bility
time more
than 3
seconds
warm extremities
capillaries, will be
4.
2.
5.
cyanosis and
edema
pallor on
extremities
Determine history of
6.
5.
That may
or traction device
restrict
Compare skin
circulation to
temperature and
limb. Helps
The patient
paresthesia
7.
differentiate
when assessing
type of
extremity circulation
problems
Assess presence,
6.
identifying or
of swelling or
quantifying
edema formation.
edema in
Measure capillary
involved
time
8.
9.
10.
11.
12.
13.
14.
Useful in
Note clients
extremity
7.
To determine
adequacy of
status
systemic
Inspect lower
extremities for skin
texture
Palpate arterial
pulses
Determine pulse
equality, as well as
intensity
Determine time that
symptoms are
worse, precipitating,
or aggravating
events
Assess motor and
sensory function
Administer
medications such as
antiplatelet agents,
thrombolytics,
antibiotics.
circulation
8.
Protein
energy
malnutrition
and weight
loss make
ischemic
tissues more
prone to
breakdown
9.
That often
accompany
diminished
peripheral
perfusion
10. To determine
level of
circulatory
blockage
11. To evaluate
distribution
and quality of
blood flow,
and success
or failure of
therapy
12. To help
isolate and
differentiate
problems
13. Problems
with
ambulation;
hypersensitivi
ty or loss of
sensation
and
numbness
and tingling
are changes
that can
indicate
neurovascula
r dysfunction
14. To improve
tissue
perfusion or
organ
function
PROBLEM # 3: Acute Pain as evidence by abdominal pain in the epigastric area secondary to intestinal obstruction
NURSING
SCIENTIFIC
S>O
DIAGNOSIS
Acute Pain as
EXPLANATION
Intestinal obstruction
O>patient
evidence
refers to a lack of
condition.
manifested:
abdominal
movement
of
of
Monitor
>pain scale of
pain
intestinal
contents
7/10
epigastric area
patientt will be
>bloatedness
secondary
Because
able to report
> + epigastric
intestinal
smaller
pain
obstruction
obstructions
ASSESSMENT
after
in
by
the
to
the
of
its
lumen,
are
OBJECTIVES
Short term:
interventions,
pain
in
epigastric
Vital signs
area.
taken:
T:36.9
RR: 21
BP: 150/170
the
cause
location,
Assess
2.
the
3.
4.
made
of
about
3.
interventio
n is more
as soon as it
likely to be
begins
successful
provide comfort
in
alleviating
position
-flank pain
example, twisting of
-distraction/
the
guarding
behaviors
obstruction, whereas
-increased
provide
such
pain
of
4.
non-
quiet,
relaxing
pharmacol
environment
ogical pain
6.
5.
encourage
which
-diaphoresis
and discomfort.
activities
-sleep
disturbance
7.
to provide
adequate
diversional
to provide
mgmt.
progressive
-pallor
timely
pt to report pain
situation.
obstruction
the
-weakness
elevated BP
be
choices
change
or
info
encourage
gradually developing
PR,RR,
exact
treatment
manifest:
to
shall reported
pain
measures
leads
data
in
acute problem or a
could
the
can
of
rest
like
socialization with
periods
and
rhythmic
prevent
breathing
fatigue
6.
Administer
analgesics
ordered
as
OUTCOME
Short
term:
baseline
assessment
may
5.
gather
significant
may manifest as an
tumor
To
comprehensive
The patient
For
2.
perform
feelings
and
1.
and
verbalization
obstruction
intestine
pts
record pts VS
decreased
well. Depending on
1.
EXPECTED
RATIONALE
INTERVENTIONS
nursing
eating
HR: 116
NURSING
to
these
could draw
the
pts
attention
away from
the pain
patient
decreased
flank pain
in
NURSING
DIAGNOSIS
Activity
intolerance r/t
EXPLANATION
Pain is an unpleasant
sensory and emotional
Short term:
After 2 hours
NURSING INTERVENTIONS
1. Establish rapport
2. Monitor VS
3. Note patients response
primarily associated
will identify
negative factors
affecting activity
as damage, or both
intolerance and
eliminate or
T:36.9
in performing activities
reduce their
degree of assistance
RR: 21
HR: 116
BP: 150/170
experienced with
certain movements.
OBJECTIVES
experience which I
manifested:
pain
SCIENTIFIC
immobility
Further difficulty with
mobility
May develop
insomnia due to
severe pain
effects when
possible.
of weakness, fatigue,
pain, difficulty
accomplishing tasks
and/or insomnia
4. Ascertain ability to stand
necessary/use of
equipment
5. Provide comfort
measures and provide
for relief for pain
6. Encourage patient to
maintain positive
attitude.
7. Instruct patient/SO (s) in
monitoring response
to activity
8. Plan for progressive
increase of activity
level, as tolerated by
the patient
9. Involve patient/SO (s) in
planning of activities
RATIONALE
1. To gain patient and
trust and
cooperation
2. To obtain baseline
data
3. Symptoms may be
result of/or
contribute to
activity
intolerance
4. To determine
current status
and needs
associated with
participation in
needed/desired
activities
5. Enhance ability to
participate in
activities
6. To enhance sense of
well being
7. To indicate need to
alter activity level
8. Both activity
tolerance and
health status may
improve with
progressive
EXPECTED
OUTCOME
Short term:
The patient
shall have
identified negative
factors affecting
activity intolerance
and eliminate or
reduce their
effects when
possible
PROBLEM #5: Readiness for enhanced knowledge as evidence by expressing interest in learning about disease
condition
ASSESSMENT
NURSING
SCIENTIFIC
DIAGNOSIS
EXPLANATION
OBJECTIVES
NURSING
INTERVENTIONS
1.
S:
Establish
RATIONALE
1.
EXPECTED
OUTCOME
To build a
Readiness for
Short term:
therapeutic
good and
Short term:
enhanced
After 1 hour of
relationship
trusting
The patient
O : The patient
knowledge as
nursing
Assess patients
relationship
shall have
manifested the
evidence by
interventions, the
general condition
with the
verbalized
following:
expressing
patient will
patient
understanding
interest in
readiness to engage
verbalize
To assess
of information
to health
learning about
understanding of
signs
for
gained.
teachings
disease
information
Verify clients
complicatio
given
condition
gained.
level of
ns
Listens intently
2.
3.
4.
Assessing a patients
knowledge about
knowledge
readiness to respond to
specific topic
assess for
of the topic
wellness diagnosis
Assist client to
complicatio
Explains
5.
involves patient
identify learning
The patient
interviews and
goals
may manifest:
interaction. And
Anxiety
Restlessness
Fear
To note and
ns
4.
Provides
Ascertain
opportunity
preferred
to ensure
management describes
methods of
accuracy
learning
and
Assist client to
completene
identify ways to
ss of
following
knowledge
recommendations and
information in all
base for
appropriate areas
future
6.
3.
7.
for herself.
learning
5.
Helps to
frame or
focus
content to
be learned
6.
Identifies
best
approach to
facilitate
learning
7.
Ability to
apply or
use
information
increases
desire to
learn and
retain
information
DATE ORDERED,
MANAGEMENT/
DATE PERFORMED,
TREATMENT
DATE CHANGE
GENERAL
INDICATION OR
DESCRIPTION
PURPOSES
D5LR 1L X 8 HRS
Date ordered:
July 2, 2015
Treatment for
persons
needing extra
calories who
Date of Results:
cannot tolerate
July 2, 2015
fluid overload.
CLIENTS
RESPONSE TO
TREATMENT
The patient willingly
accepted treatment
and is kept hydrated
as evidenced by
continuous infusion,
Treatment of
improvement in his
shock.
NURSING RESPONSIBILITIES:
BEFORE THE PROCEDURE:
1. Assess vital signs for baseline data, skin turgor, bleeding tendencies, disease or
2.
3.
4.
5.
6.
7.
b. Drugs
NAME OF
DATE
ROUTE OR
DRUGS,
ORDERED,
ADMINISTRATION
GENERIC
DATE
DOSAGE AND
NAME, BRAND
TAKEN/GIVEN,
FREQUENCY OF
NAME
DATE CHANGED
ADMINISTRATION
GENERAL
CLIENTS
ACTION,
INDICATION OR
RESPONSE TO
MECHANISM OF
PURPOSES
THE
ACTION
MEDICATION
General action:
Generic name:
Date ordered:
OMEPRAZOLE
July 2, 2015
Brand names:
LOSEC
Date of Results:
July 2, 2015
Antiulcer
It is use to
decrease the
not experience
Mechanism of
amount of acid
any adverse
Action:
produced in the
effect.
40 mg TIV O.D.
PRILOSEC
activity by
binding to
hydrogenpotassium
adenosine
triphosphatase,
located at
secretory
surface of
gastric parietal
cells, to
suppress
gastric acid
secretion.
Nursing Responsibilities
BEFORE
1. Observe 10 Rs of administration of drugs
2. Check doctors order three times and verify the patient
3. Check the label of the drug, its name and its expiration date
4. Wash hands before handling the medication
stomach
NAME OF
DATE ORDERED,
DRUGS,
DATE
GENERIC NAME,
TAKEN/GIVEN,
BRAND NAME
DATE CHANGED
ROUTE OR
ADMINISTRATION
DOSAGE AND
FREQUENCY OF
ADMINISTRATION
GENERAL
ACTION,
MECHANISM OF
ACTION
INDICATION
OR
PURPOSES
Generic name:
Date ordered:
CEFUROXIME
July 2, 2015
Brand names:
Serious lower
Antibiotic
respiratory tract
infection, UTI,
Mechanism of
skin or skin-
Action:
structure
CEFTIN,
Inhibits cell-wall
infections, bone
ZINACEF
synthesis,
of joint
promoting osmotic
infection,
instability; usually
septicema,
bactericidal.
meningitis and
KEFUROX,
Date of Results:
750 g TIV Q8
General action:
July 2, 2015
gonorrhea
- Pharyngitis
and tonsillitis
- Early lyme
disease
Nursing Responsibilities
BEFORE
6. Observe 10 Rs of administration of drugs
7. Check doctors order three times and verify the patient
8. Check the label of the drug, its name and its expiration date
9. Wash hands before handling the medication
10. Assess patients vital signs prior to administering the medication
DURING
5. Administer as indicated (right drug, right dosage, right frequency)
6. Clean the IV insertion for medication with a cotton ball with alcohol.
7. Gradually inject the drug into the port. Slow IV push to prevent infiltration and
phlebitis.
8. Administer cautiously and slowly with aseptic technique.
AFTER
5. Observe for the sensitivity and side effects to the drug
6. Reassess patients level of pain at least 15 and 30 minutes after parenteral
administration
7. Monitor circulatory and respiratory status and bladder and bowel function.
8. Caution ambulatory patient about getting out of bed or walking.
NAME OF DRUGS,
GENERIC NAME,
BRAND NAME
DATE ORDERED,
DATE
TAKEN/GIVEN,
DATE CHANGED
ROUTE OR
ADMINISTRATION
DOSAGE AND
FREQUENCY OF
ADMINISTRATION
GENERAL
ACTION,
MECHANISM OF
ACTION
INDICATION
OR PURPOSE
Generic name:
METRONIDAZOLE
Date ordered:
July 2, 2015
500 mg TIV Q8
General action:
- Amebic Liver
Antiprotozoal
abscess
- Intestinal
Brand names:
FLAGYL, FLAGYL
Date of Results:
July 2, 2015
Mechanism of
amebiasis
action:
- Trichomonias
ER, FLORAZOLE
Direct acting
ER, NOVO-
trichomonicide and
NIDAZOLE,
amebicide that
FLAGYL IV RTU
Nursing Responsibilities
BEFORE
11. Observe 10 Rs of administration of drugs
12. Check doctors order three times and verify the patient
13. Check the label of the drug, its name and its expiration date
14. Wash hands before handling the medication
15. Assess patients vital signs prior to administering the medication
DURING
9. Administer as indicated (right drug, right dosage, right frequency)
10. Clean the IV insertion for medication with a cotton ball with alcohol.
11. Gradually inject the drug into the port. Slow IV push to prevent infiltration and
phlebitis.
12. Administer cautiously and slowly with aseptic technique.
AFTER
9. Observe for the sensitivity and side effects to the drug
10. Reassess patients level of pain at least 15 and 30 minutes after parenteral
administration
11. Monitor circulatory and respiratory status and bladder and bowel function.
12. Caution ambulatory patient about getting out of bed or walking.
c. Diet
TYPE OF DIET
DATE ORDERED,
GENERAL
INDICATION
DATE
DESCRIPTION
SPECIFIC FOOD
CLIENT'S
TAKEN
RESPONSE AND
TAKEN/GIVEN,
REACTION TO
DATE CHANGED
THE DIET
NPO
Date ordered:
Orem)
July 2, 2015
stands
for
which
through mouth.
means
nothing by mouth.
Date of Results:
July 2, 2015
Patient cannot
orders
when
for
None
TYPE OF DIET
NGT
DATE ORDERED,
GENERAL
DATE
DESCRIPTION
INDICATION
SPECIFIC FOOD
CLIENT'S
TAKEN
RESPONSE AND
TAKEN/GIVEN,
REACTION TO
DATE CHANGED
THE DIET
Date ordered:
July 2, 2015
Date of Results:
July 2, 2015
none only
As stated by the
medications
patient, there's a
feeling of
discomfort.